Open AccessLung cancer in older patients
Author(s) -
Dmitry A. Kharagezov,
Ю. Н. Лазутин,
Sergey P. Pyltsin,
Anton G. Milakin,
О. Н. Статешный,
Igor A. Leyman,
Э. А. Мирзоян
Publication year - 2021
Publication title -
innovacionnaâ medicina kubani
Language(s) - English
Resource type - Journals
eISSN - 2541-9897
pISSN - 2500-0268
DOI - 10.35401/2500-0268-2021-22-2-65-71
Subject(s) - life expectancy , medicine , disease , lung cancer , cancer , radiation therapy , stage (stratigraphy) , population , performance status , chemotherapy , intensive care medicine , public health , gerontology , surgery , oncology , environmental health , pathology , paleontology , biology
Increasing life expectancy is the goal of social programs in the Russian Federation as a reflection of the success of public health. Globally, there is a trend for aging of the population, contributing to an increased risk for lung cancer developing which is primarily a disease of the elderly. Chronologic age or performance scores alone are not accurate predictors of patients’ capacity for tolerating aggressive cancer therapies. Use of a comprehensive geriatric assessment to determine treatment strategy is able to reduce toxicities and treatment failures. Safe elderly patients are often able to tolerate surgical resection, radiation, and/or chemotherapy appropriate for their tumor stage, with outcomes similar to those of younger patients, albeit with higher rates of treatment-related toxicity.